National Health (Medication chart prescription trial hospital) Amendment Declaration 2015 (No. 2) (PB 76 of 2015)

Overview

The National Health (Medication chart prescription trial hospital) Amendment Declaration 2015 (No. 2) was enacted to address the need for improved efficiency in the prescribing, dispensing, and claiming of Pharmaceutical Benefits Scheme (PBS) medications within hospitals. This Amendment Declaration, made under subregulation 59(3) of the National Health (Pharmaceutical Benefits) Regulations 1960, was issued by the Australian Parliament to extend participation in the paper-based medication chart prescription trials to additional approved public and private hospitals, while also removing one hospital from the trial. The purpose of these amendments is to enhance health professional workflow and ultimately improve health outcomes for patients by reducing duplication and streamlining the medication prescription process within hospitals. The Amendment Declaration aligns with the broader objective of the Regulations to facilitate the use of hospital medication charts for PBS purposes, thereby supporting the progressive realisation of the right to the highest attainable standard of physical and mental health as declared in the International Covenant on Economic, Social and Cultural Rights.

Scope and Application

The National Health (Medication chart prescription trial hospital) Amendment Declaration 2015 (No. 2) amends the National Health (Pharmaceutical Benefits) Regulations 1960 by declaring additional approved hospitals as 'listed approved hospitals' for the purpose of participating in trials for paper-based medication chart prescriptions. This amendment applies to specific approved public and private hospitals that meet the trial site participation eligibility criteria as determined by the Australian Commission on Safety and Quality in Health Care. The amendment facilitates the use of hospital medication charts for prescribing, dispensing, and claiming for pharmaceutical benefits under the Pharmaceutical Benefits Scheme and the Repatriation Pharmaceutical Benefits Scheme, without the need for separate prescriptions. The Amendment Declaration removes one hospital from the trial, while including several others, and is designed to increase efficiencies and improve workflow for health professionals, thereby potentially enhancing health outcomes for patients. The Amendment Declaration operates on a Commonwealth level, as it amends regulations under the National Health Act 1953. The changes will take effect on the day after the Amendment Declaration is registered on the Federal Register of Legislative Instruments. The Amendment Declaration is compatible with human rights, particularly Articles 2 and 12 of the International Covenant on Economic, Social and Cultural Rights, as it contributes to the progressive realisation of the right to the highest attainable standard of physical and mental health by providing subsidised access to medicines and reducing duplication in the prescribing process.

Key Provisions

The main operative sections of the National Health (Medication chart prescription trial hospital) Amendment Declaration 2015 (No. 2) (the Amendment Declaration) pertain to the declaration of additional approved hospitals as 'listed approved hospitals' for the purposes of a paper-based medication chart prescription trial (subregulation 59(3)). This Amendment Declaration is made under the authority of the National Health (Pharmaceutical Benefits) Regulations 1960, and it serves to augment the trial by including more hospitals while also removing one hospital from the trial. The intent behind this amendment is to facilitate increased efficiencies in the use of hospital medication charts for prescribing, dispensing, and claiming pharmaceutical benefits under the Pharmaceutical Benefits Scheme (PBS) and the Repatriation PBS (RPBS). The Amendment Declaration imposes certain obligations on the parties involved, particularly the hospitals designated as listed approved hospitals. These hospitals must meet the trial site participation eligibility criteria as administered by the Australian Commission on Safety and Quality in Health Care (ACSQHC) to ensure they are ready to participate in the trial. The Amendment Declaration requires these hospitals to implement the use of medication chart prescriptions in accordance with the regulations set out in the National Health (Pharmaceutical Benefits) Regulations 1960. This involves streamlining the prescribing process by eliminating the need for separate prescriptions for PBS and RPBS purposes, thereby improving workflow and reducing duplication for health professionals. Any breach of the obligations imposed by the Amendment Declaration may lead to civil or criminal consequences, although specific penalties are not detailed within the explanatory statement. Generally, under the National Health Act 1953, non-compliance with regulations related to the PBS could result in fines or other civil penalties. For hospitals participating in the trial, failure to adhere to the prescribed standards could impact their eligibility to continue in the trial and potentially their standing as approved hospitals under the PBS. The precise penalties for breaches are likely to be specified within the broader framework of the National Health Act 1953 and related regulations.